The ALPS Medical Breakthroughs ETF (SBIO) was ALPS' top-performing ETF in August, propelled by positive earnings and M&A announcements in the portfolio. SBIO increased 8.65% on a total return basis ...
Biotech ETFs may be on the rise at least in part thanks to their exposure to a defensive sector in the form of health care, but still, their performance is notable because many biotech names grow ...
With most of the First World and China aging fast and the elderly spending more on health needs than younger folks, that should play well with health/medical sector stocks. That said, pressures on ...
KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (ALPS) (the “Company” or “Alps Group”), the parent company of Alps Life Sciences Inc. (“Alps Holdco”), a fully integrated ...
ALPS Medical Breakthroughs ETF (SBIO) - $0.0000. Payable Dec 23; for shareholders of record Dec 18; ex-div Dec 18.
If you're interested in broad exposure to the Healthcare - Broad segment of the equity market, look no further than the ALPS Medical Breakthroughs ETF (SBIO), a passively managed exchange traded fund ...
This article was originally published on ETFTrends.com. The ALPS Medical Breakthroughs ETF (SBIO) was ALPS' top-performing ETF in August, propelled by positive earnings and M&A announcements in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results